Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing | MicrobiomeTrials← Back to trialsNCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingOBSERVATIONAL
Trial Details
Start: 2021-10-29Est. Completion: 2028-12
Enrollment target: 500 participants Locations- Banner Health, Gilbert, Arizona, United States
- Mayo Clinic Hospital, Phoenix, Arizona, United States
- City of Hope, Duarte, California, United States
- University of California San Diego, La Jolla, California, United States
- Stanford University, Palo Alto, California, United States
- UCLA Medical Center, Santa Monica, California, United States
- Mayo Clinic Jacksonville, Jacksonville, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Mayo Clinic Rochester, Rochester, Minnesota, United States
- Washington University, St Louis, Missouri, United States
- NYU Langone Medical Center, New York, New York, United States
- The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- MD Anderson Cancer Center, Houston, Texas, United States
- Fred Hutchinson Cancer Center, Seattle, Washington, United States
Other microbiome trials you might be interested in
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035
Unspecified Adult Solid Tumor, Protocol Specific
This pilot randomized clinical trial studies palliative care intervention in improving quality of life, psychological di…
Duarte, United StatesCompleted May 18, 2020
Breast NeoplasmsColorectal NeoplasmsProstate NeoplasmEndometrial NeoplasmsNeoplasm MetastasisStomach NeoplasmsEsophageal Neoplasms
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relev…
Duarte, United StatesEst. completion Apr 2030